PhysicalTherapy.com Phone: 866-782-6258


Aromatase Inhibitors: What Are They and Who Is Taking Them?

Andrea Branas, PT, MSE, MPT, CLT

March 26, 2014

Share:

Question

For what are Aromatase Inhibitors prescribed?  Are all cancer patients on them?

Answer

Aromatase inhibitors are typically prescribed as an on-going treatment for women who have an estrogen-positive breast cancer diagnosis.  Not all women with breast cancer have estrogen-positive breast cancer.  This means that with some patients, it does not matter how much estrogen is in their body as it does not affect their breast cancer.  However, for other women, estrogen feeds their breast cancer.  We want to limit the amount of estrogen in their bodies.  Aromatase inhibitors are used to limit free floating estrogen.  Typically, those women will have surgery followed by radiation and chemotherapy.  Then, they will be put on aromatase inhibitors, which are in pill form.  They will take these pills for up to 5 years post diagnosis.  Currently, trials are looking at how long of a duration is truly needed; should they stay on them for 5 years?  More?  Less?  The jury is still out.  


andrea branas

Andrea Branas, PT, MSE, MPT, CLT

Andrea Branas is a lead physical therapist at Good Shepherd Penn Partners in Philadelphia, PA.  Andrea works in the Abramson Cancer Center at the University of Pennsylvania Health System providing patient care, education, leadership and training in the area of cancer rehabilitation.  Andrea’s areas of clinical expertise include lymphedema, pelvic floor rehabilitation, breast cancer rehabilitation and exercise for cancer related fatigue. In her current role, Andrea uses her expertise to help cancer survivors reach their physical potential by promoting rehabilitation starting at the time of cancer diagnosis.  She is currently a collaborator on an NIH Funded Dissemination grant to look at strength training for survivors of breast cancer.   Andrea has served as a guest lecturer for women’s health and cancer content at Arcadia and Widener Universities and the University of Medicine and Dentistry in New Jersey DPT programs. Andrea received her Masters degree in Physical Therapy from the University of the Sciences in Philadelphia in 1998 and her Master’s of Science in Engineering degree from the University of Pennsylvania in 1991.  She is currently working towards her transition DPT at Arcadia University. 


Related Courses

Cancer Related Comorbidities and Adverse Treatment Effects
Presented by Stephen Morris, PT, PhD, FACSM
Recorded Webinar

Presenter

Stephen Morris, PT, PhD, FACSM
Course: #3592Level: Intermediate2 Hours
  'We need more courses on oncology PT as it is not well researched'   Read Reviews
Cancer and its treatment are known to cause survivors to experience a number of comorbidities and adverse effects. Because physical therapy management of the cancer survivor must either focus on these comorbidities/adverse effects or treat them, physical therapists must have a fundamental understanding of the most common of conditions. This course is directly related to the practice of physical therapy and is therefore appropriate for the PT/PTA.

Upper Extremity Neuropathies in Oncology
Presented by Amanda Koenning, PT, DPT, OCS
Live WebinarFri, Jan 24, 2025 at 12:00 pm EST
Fri, Jan 24, 2025 at 12:00 pm EST

Presenter

Amanda Koenning, PT, DPT, OCS
Course: #5137Level: Intermediate2 Hours
This course aims to explore upper extremity neuropathies within the oncology setting, including chemotherapy-induced peripheral neuropathy, cervical radiculopathy, thoracic outlet syndrome, and peripheral median and ulnar nerve neuropathies. Included case studies provide real examples of peripheral neuropathies in the oncology setting.

Oncologic Pharmacology for the Rehabilitation Professional
Presented by Stephen Morris, PT, PhD, FACSM
Recorded Webinar

Presenter

Stephen Morris, PT, PhD, FACSM
Course: #3894Level: Intermediate2 Hours
  'very good and knowledgeable speaker'   Read Reviews
A vast array of drugs are used to treat patients with cancer. This webinar will introduce the attendee to the basic pharmacology of these drugs, the mechanism of action of different classes of these drugs, and frequently observed adverse effects of these drugs. This course is directly related to the practice of physical therapy and is therefore appropriate for the PT/PTA.

Mindfulness: Beyond Guided Meditation
Presented by Jennifer Stone, PT, DPT, OCS, PHC, TPS, HLC
Recorded Webinar

Presenter

Jennifer Stone, PT, DPT, OCS, PHC, TPS, HLC
Course: #3902Level: Intermediate2 Hours
  'She had a calming and effective style'   Read Reviews
Mindfulness can be a really powerful cognitive-behavioral tool and has many relevant applications when treating patients with pain, especially chronic pain. Many courses for rehabilitation professionals teach guided meditation, which is an amazing tool. However, mindfulness has many other applications and opportunities for use in the treatment of patients with pain. This session discusses the history and science behind mindfulness, as well as provides a variety of practical mindfulness tools for the everyday practitioner. This course is directly related to the practice of physical therapy and is therefore appropriate for the PT/PTA.

Medical Screening – Part 3 Adult
Presented by Dawn T. Gulick, PT, PhD, ATC, CSCS
Recorded Webinar

Presenter

Dawn T. Gulick, PT, PhD, ATC, CSCS
Course: #4475Level: Advanced2 Hours
  'Multiple clinical pearls and a guide to looking for symptoms of concern when working with adult patients'   Read Reviews
This course focuses on medical screening for the physical therapist and is Part 3 of a four-part series on screening. Part 3 addresses pathology in the adult portion of the lifespan. Part 1 is recommended prior to part 3.

Editor's Note: Regarding Pennsylvania credits, this course is approved by the PA State Board of Physical Therapy for 2 hours of Direct Access CE credit.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.